ArticleChest2016

Sirolimus Therapy for Patients With Lymphangioleiomyomatosis Leads to Loss of Chylous Ascites and Circulating LAM Cells.

Sergio Harari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.